On Tuesday, Revvity got a positive adjustment to its Relative Strength (RS) Rating, from 70 to 76.
This unique rating tracks market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks stacks up against all the other stocks in our database.
Decades of market research reveals that the best-performing stocks typically have an RS Rating north of 80 in the early stages of their moves. See if Revvity can continue to rebound and clear that threshold.
How To Invest In Stocks In Both Bull And Bear Markets
Revvity is trying to complete a consolidation with a 129.50 entry. See if the stock can clear the breakout price in heavy trading.
In terms of top and bottom line numbers, the company has posted rising EPS growth over the last four quarters. Revenue growth has also risen over the same time frame.
The company holds the No. 2 rank among its peers in the Medical-Research Equipment/Services industry group. Revvity is the No. 1-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
RELATED:
Which Stocks Are Showing Improved Price Performance?
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
